genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Genetic Disease Testing
Multiomics Approach Improves Diagnosis of Rare Disease, Methylmalonic Aciduria
Base Editing
Zinc Finger Design AI Tool Opens Door to Large-Scale Gene Therapies
Cancer
Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer
Cancer’s Capacity to Resist Treatment Thwarted
Animal Models
Microbiome and its Metabolites Promote Endometriosis in Animal Model
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Drug Discovery
High-Content Analysis
High-Content Analysis
ADME/TOX
Antibodies
Assay Development
Cell-Based Assays
Drug Delivery
Drug Interactions
Drug Repositioning
Druggable Genome
GPCRs
High-Content Analysis
High-Content Screening
High-Throughput Screening
Outsourcing
Small Molecules
Target Identification
Therapeutics
Vaccine Development
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
High-Content Analysis
An Optimized High-Content Imaging Workflow for 3D Spheroid Cell Models
High-Content Analysis
Bayer Taps ChromoTek’s Drug Profiling Technology
High-Content Analysis
Plexpress to Raise up to $2.3M to Commercialize Multiplex Gene-Expression Analysis Platform
High-Content Analysis
Leica Microsystems and Definiens Ink Co-Marketing Agreement for Imaging and High-Content Analysis Products
High-Content Analysis
ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market
Scroll Up
Login
Subscribe
![Acquired company comes with Cellumen’s Cellular Systems Biology IP and assets. [© Alexander Raths - Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug6_2010_7868578_WomanWithLabware_CyprotexBuysApredica7753313689-265x198.jpg "ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market")
